Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Adalimumab in the Treatment of Acute Vogt-Koyanagi-Harada Disease

NCT05590416 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT05590416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05590416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Adalimumab in the Treatment of Acute Vogt-Koyanagi-Harada Disease
Lead sponsor
Tianjin Medical University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
December 30, 2024
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adalimumab, vogt-koyanagi-harada disease